ImpediMed Limited (ASX.IPD) has confirmed that the inaugural SOZO Heart Failure Programme has been established at Advocate Health Care’s Heart Institute in Chicago Illinois.
The study is being conducted under the guidance of Dr Ali Valika, MD, an interventional cardiology specialist board certified in Advanced Heart Failure and Transplant Cardiology.
Advocate AuroraHealth consists of 26 hospitals and over 500 sites of care. Advocate Health Care in Illinois and Aurora Health Care in Wisconsin together form one of the premier, not-for-profit health systems in the United States.
Advocate Aurora Health is nationally recognised for clinical expertise across the care continuum while leading health care transformation to drive value and reimagine the consumer experience.
Within Advocate Health Care is the Advocate Heart Institute with over 100 sites, where 350 specialists perform more than 20,000 heart procedures each year, the most in Illinois. They are a national leader in heart outcomes and pride themselves on pioneering the most advanced programs and technology.
The introduction of SOZO is being championed by Dr Ali Valika, with the aim of optimising fluid levels in Heart Failure Patients both in clinic and after discharge. He currently practices at Advocate Health Midwest Heart Specialists and is affiliated with Advocate Good Samaritan Hospital.
ImpediMed was able to leverage its existing footprint within the Advocate Aurora Health system to move forward with an initial Heart Failure Programme. The Advocate Aurora Health system currently has 10 SOZO devices under a Lymphoedema Prevention Programme.
After the significant COVID-19 delays it is fantastic to initiate the SOZO heart failure program at such a highly respected/credentialed medical institution. We are looking forward to working with Dr. Valika and his team in advancing the use of SOZO and improving outcomes in the heart failure patients,” Richard Carreon, Managing Director and CEO of ImpediMed, said.
“We are expecting other hospitals to initiate SOZO heart failure programmes shortly, adding to the clinical and reimbursement evidence required to underpin widespread commercialisation.”
Founded and headquartered in Brisbane, Australia with USand European operations, ImpediMed is a medical technology company that uses bioimpedance spectroscopy (BIS) technology to generate powerful data to maximise patient health.
ImpediMed produces a family of FDA cleared and CE Marked medical devices, including SOZO for multiple indications including heart failure, lymphoedema, and protein calorie malnutrition sold in select markets globally.
